COVID-19 treatment during and after recovery: What to expect

  • Ari Fahrial Syam Medical Faculty, Universitas Indonesia-Cipto Mangunkusumo Hospital
Keywords: remdesivir, choloroquin, plasma convalescent, COVID-19, SARS-Cov2

Abstract

Currently, there are no clinically specific drug for COVID-19, neither novel treatments nor vaccines. Hospitals and researchers over the world are testing many different therapies on coronavirus-positive patients in an effort to find a potential COVID-19 treatment, a few medications that have been making a buzz in the science community such as remdesivir, hydroxychloroquine and chloroquine, favipiravir, oseltamifir, lopinavir/ritonavir, azithromycin, plasma convalescent, dexamethasone and stem cell.

Downloads

Download data is not yet available.

Author Biography

Ari Fahrial Syam, Medical Faculty, Universitas Indonesia-Cipto Mangunkusumo Hospital
Department of Internal Medicine

Submitted

2020-10-06
Accepted
2020-10-26
Published
2020-10-27
Section
Articles